The DOI matches its Crossref record.
The prognostic importance of left ventricular geometry in uremic cardiomyopathy.
Abstract
The objective of this study was to determine the effect of left ventricular (LV) mass, volume, and mass-to-volume ratio on mortality in chronic dialysis patients. The Design was a multicenter, prospective inception cohort study with a median follow-up of 41 months. The Setting was three university-affiliated nephrology units. A total of 433 patients who (1) survived > 6 months from the start of ESRD therapy and (2) had a technically satisfactory baseline echocardiogram were studied. Measurements included a baseline clinical, laboratory and echocardiographic assessment. LV hypertrophy was present in 74% and LV dilation was present in 36% of patients. In patients with normal cavity volume (< or = 90 mL/m2) and normal systolic function, high LV mass index (> 120 g/m2) and mass-to-volume ratios (> 2.2 g/mL) were independently associated with late mortality (> 2 yr after starting dialysis therapy). After adjusting for baseline age, diabetes, and ischemic heart disease, the relative risk for the former was 3.29 and for the latter was 2.24. Cavity volume was of no prognostic significance in this group. In patients with LV dilation and normal systolic function, high cavity volume (> 120 mL/m2) and low mass-to-volume ratio (< 1.8 mL/m2) were independently associated with late mortality, the relative risk in the former being 17.14 and the latter being 4.27. LV mass index was of no prognostic significance in this group. The baseline echocardiographic classification, based on LV mass and cavity volume, was the strongest predictor of late mortality, after adjusting for age, gender, diabetes mellitus, coronary artery disease, angina pectoris, chronic hypertension, and hemoglobin and serum albumin levels.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Self-citationSarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000102971.85504.7c · Cited by 1,144
Self-citationLeft ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
Levin, A., Thompson, C. R., Ethier, J., Carlisle, E. J. F., Tobe, S., Mendelssohn, D., Burgess, E., Jindal, K., Barrett, B., Singer, J., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70118-6 · Cited by 841
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90130-4 · Cited by 769
Self-citationA meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
Klingbeil, A. U., Schneider, M., Martus, P., Messerli, F. H., & Schmieder, R. E. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00158-x · Cited by 761
The Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure
PARFREY, P. S., & FOLEY, R. N. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071606 · Cited by 653
Self-citationZoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation · doi:10.1161/hc1102.105261 · Cited by 519
Cardiac and arterial interactions in end-stage renal disease
London, G. M., Guerin, A. P., Marchais, S. J., Pannier, B., Safar, M. E., Day, M., & Metivier, F. (1996) · Kidney International · doi:10.1038/ki.1996.355 · Cited by 474
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
Foley, R. N., Parfrey, P. S., Morgan, J., Barré, P. E., Campbell, P., Cartier, P., Coyle, D., Fine, A., Handa, P., Kingma, I., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00289.x · Cited by 412
Self-citationZoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G., Giacone, G., Stancanelli, B., Cataliotti, A., & Malatino, L. S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00530.x · Cited by 363
Prevalence, Predictors, and Consequences of Late Nephrology Referral at a Tertiary Care Center
ARORA, P., OBRADOR, G. T., RUTHAZER, R., KAUSZ, A. T., MEYER, K. B., JENULESON, C. S., & PEREIRA, B. J. G. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061281 · Cited by 363
Mirza, M. A. I., Larsson, A., Melhus, H., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.013 · Cited by 341
Outcome and risk factors of ischemic heart disease in chronic uremia
Parfrey, P. S., Foley, R. N., Harnett, J. D., Kent, G. M., Murray, D., & Barre, P. E. (1996) · Kidney International · doi:10.1038/ki.1996.201 · Cited by 325
Self-citationZOCCALI, C., MALLAMACI, F., BENEDETTO, F. A., TRIPEPI, G., PARLONGO, S., CATALIOTTI, A., CUTRUPI, S., GIACONE, G., BELLANUOVA, I., COTTINI, E., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271508 · Cited by 320
Associations between Kidney Function and Subclinical Cardiac Abnormalities in CKD
Park, M., Hsu, C.-Y., Li, Y., Mishra, R. K., Keane, M., Rosas, S. E., Dries, D., Xie, D., Chen, J., He, J., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020145 · Cited by 319
Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment
Neumann, J., Ligtenberg, G., Klein, I. I., Koomans, H. A., & Blankestijn, P. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00552.x · Cited by 304
Left Ventricular Hypertrophy in the Renal Patient
MIDDLETON, R. J., PARFREY, P. S., & FOLEY, R. N. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251079 · Cited by 294
Self-citationPrognostic Impact of the Indexation of Left Ventricular Mass in Patients Undergoing Dialysis
Zoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G., Giacone, G., Cataliotti, A., Seminara, G., Stancanelli, B., & Malatino, L. S. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122768 · Cited by 292
The cardiovascular effects of erythropoietin
Smith, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00468-1 · Cited by 276
Ayus, J. C., Mizani, M. R., Achinger, S. G., Thadhani, R., Go, A. S., & Lee, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040392 · Cited by 265
Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging
Mark, P. B., Johnston, N., Groenning, B. A., Foster, J. E., Blyth, K. G., Martin, T. N., Steedman, T., Dargie, H. J., & Jardine, A. G. (2006) · Kidney International · doi:10.1038/sj.ki.5000249 · Cited by 262
Chronic kidney disease and cardiovascular complications
Di Lullo, L., House, A., Gorini, A., Santoboni, A., Russo, D., & Ronco, C. (2015) · Heart Failure Reviews · doi:10.1007/s10741-014-9460-9 · Cited by 262
Long-term evolution of cardiomyopathy in dialysis patients
Foley, R. N., Parfrey, P. S., Kent, G. M., Harnett, J. D., Murray, D. C., & Barre, P. E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00154.x · Cited by 226
Self-citationStenvinkel, P. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_5.32 · Cited by 97
Yoon, C.-Y., Park, J., Seo, C., Nam, B. Y., Kim, S., Kee, Y. K., Lee, M., Cha, M.-U., Kim, H., Park, S., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2907 · Cited by 8
Metadata
- Authors
- Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barré, P. E.
- Venue
- Journal of the American Society of Nephrology
- Published
- 1995-06
- Volume
- 5
- Issue
- 12
- Pages
- 2024-2031
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2270719279
- Cited by
- 480
- References
- 0
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.